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Abstract
Hematopoiesis is a tightly regulated biological process that relies upon complicated interactions between blood cells and
their microenvironment to preserve the homeostatic balance of long-term hematopoietic stem cells (LT-HSCs), short-term
HSCs (ST-HSCs), multipotent progenitors (MPPs), and differentiated cells. Adhesion molecules like P-selectin (encoded by
the Selp gene) are essential to hematopoiesis, and their dysregulation has been linked to leukemogenesis. Like HSCs,
leukemic stem cells (LSCs) depend upon their microenvironments for survival and propagation. P-selectin plays a crucial role
in Philadelphia chromosome -positive (Ph
+) chronic myeloid leukemia (CML). In this paper, we show that cells deficient in P-
selectin expression can repopulate the marrow more efficiently than wild type controls. This results from an increase in HSC
self-renewal rather than alternative possibilities like increased homing velocity or cell cycle defects. We also show that P-
selectin expression on LT-HSCs, but not ST-HSCs and MPPs, increases with aging. In the absence of P-selectin expression,
mice at 6 months of age possess increased levels of short-term HSCs and multipotent progenitors. By 11 months of age,
there is a shift towards increased levels of long-term HSCs. Recipients of BCR-ABL-transduced bone marrow cells from P-
selectin-deficient donors develop a more aggressive CML, with increased percentages of LSCs and progenitors. Taken
together, our data reveal that P-selectin expression on HSCs and LSCs has important functional ramifications for both
hematopoiesis and leukemogenesis, which is most likely attributable to an intrinsic effect on stem cell self-renewal.
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Introduction
Hematopoietic stem cells (HSCs) rely upon exquisite interac-
tions with each other and their microenvironments to fulfill their
specific cellular functions. HSCs are responsible for the mainte-
nance of the blood cell pool and can fulfill this function because of
their unique capacities to self-renew and to differentiate into
functioning blood cells. Proper hematopoietic homeostasis is
essential in order to preserve the appropriate balance of long-
term HSCs (LT-HSCs), short-term HSCs (ST-HSCs), and multi-
potent progenitors (MPPs). To achieve this, HSCs must be
regulated and maintained through assorted growth factors, cell
cycle regulation, transcription factors, epigenetic modulation, and
interactions with the microenvironment [1,2].
P-selectin is a well-studied adhesion protein known to be
expressed on the surface of activated endothelial cells and platelets
[3]. We have previously shown that P-selectin plays a crucial role
in Philadelphia chromosome -positive (Ph
+) chronic myeloid
leukemia (CML) [4]. The mechanism by which the lack of P-
selectin was thought to promote the rate of CML appeared to
involve the capacity of these leukemic cells to be retained in the
bone marrow through adhesive interactions with the stroma. This
defect had been thought to be related to the stroma and not to the
leukemic stem cell (LSC) itself. Here, we investigate the role of P-
selectin plays on HSC- and LSC-containing lin low/Sca-1
+/c-kit
+
(LSK) cells. We demonstrate that the loss of P-selectin expression
leads to an increased capacity to repopulate the bone marrow in
both the short- and long-term. We show that this is likely due to an
enhanced capacity for self-renewal. We also demonstrate with our
retroviral transduction/transplantation BCR-ABL-induced CML
mouse model that the loss of P-selectin expression on LSC-
containing LSK cells significantly increased the severity of the
disease. We show that aging mice exhibit elevated levels of P-
selectin on the surfaces of their LT-HSCs (CD34
2 LSK) but not
their ST-HSCs and MPPs (CD34
+ LSK).
Materials and Methods
Mouse strains
Wild type C57BL/6J mice (WT hereafter), transgenic WT mice
ubiquitously expressing eGFP (C57BL/6-Tg[UBC-GFP]
30Scha/J;
UBC-GFP hereafter), congenic WT mice expressing CD45.1
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b/
BoyJ; CD45.1 hereafter), and WT mice with
homozygous null mutations in the gene encoding the P-selectin
protein (B6.129S7-Selp
tm1Bay; Selp
2/2 hereafter) were obtained
from The Jackson Laboratory (Bar Harbor, ME) and maintained
in accordance with the standards set forth by the institution’s
Animal Care and Use Committee.
Bone marrow transduction and transplantation
As previously described, the cDNA encoding the p210
isoform of BCR-ABL was subcloned into the retroviral MSCV-
IRES-eGFP (MIG) in order to make the bicistronic MIG-p210
plasmid construct [4,5,6]. Helper-free, ecotropic retroviral
stocks of MIG and MIG-p210 were generated by transient
transfection of 293T/17 cells with the respective constructs.
Viral titers were determined by analyzing the percentage of
GFP
+ cells following infection of NIH3T3 cells with serial
dilutions of retroviral stock.
A CML-like myeloproliferative disease can be induced
following transplantation of bone marrow cells derived from 5-
fluorouracil (5-FU)-pretreated donor mice, pre-stimulated with
IL3, IL6, and stem cell factor (SCF), and transduced with
retrovirus encoding BCR-ABL (MIG-p210) [5]. As previously
described, 12-week-old female donor mice (Selp
2/2 or WT) were
pretreated with 5-FU (200 mg/kg) via lateral tail vein injection
[4,5,6]. Four days post-injection, donor mice were sacrificed, and
bone marrow cells were harvested. Cells were pre-stimulated with
IL3, IL6, and SCF and subjected to two rounds of co-
sedimentation/infection with high-titer MIG-p210 retroviral
stock. Cells were collected and transplanted into irradiated (2
rounds of 550 cGy) WT mice (2610
5 cells/mouse). Twelve-week-
old female WT recipient mice were closely monitored for
outward signs of CML-like disease. For the assay designed to
test the role of aging on leukemogenesis, we used 15-month-old
Selp
2/2 and WT male mice for donors and transplanted 2.0610
5
cells into each irradiated 3-month-old WT male recipient.
Hematopoietic tissues and peripheral blood were collected from
sick mice at specific time points in order to characterize the onset
and development of disease. For the whole bone marrow
repopulation study, we transduced 5-FU pretreated bone marrow
cells derived from 12 week old female Selp
2/2 a n dW Tm i c ea n d
pre-stimulated with IL3, IL6, and SCF. These cells were then
subjected to two rounds of retroviral infection with a construct
encoding GFP (MIG) and transplanted via lateral tail vein
injection into irradiated (2 rounds of 550 cGy) 12 week-old
female WT mice (2610
5 cells/mouse).
Bone marrow transduction efficiency assay
As previously described, 12-week-old female donor mice (Selp
2/2
or WT) were pre-treated with 5-FU (200 mg/kg) via lateral tail vein
injection [4,5,6]. Four days post-injection, donor mice were
sacrificed, and bone marrow cells were harvested. Cells were pre-
stimulated with IL3, IL6, and SCF and subjected to two rounds of
co-sedimentation/infection with high-titer MIG-p210 retroviral
stock. The virus-transduced bone marrow cells were cultured for
48 h. Then, those bone marrow cells were analyzed to determine
the percentage of GFP
+Lin
-cKit
+Sca-1
+ cells by FACS.
In vitro culture of LSCs
Bone marrow cells were isolated from CML mice and were
cultured in vitro in the presence of StemSpan SFEM (Stem Cell
Technologies, Vancouver, CA), stem cell factor, insulin-like
growth factor-2, thrombopoietin, heparin, and fibroblast growth
factor, as described previously [7,8].
Cell cycle analysis of HSCs
Cell cycle status was assessed by staining cells with 5 uM
Hoechst blue for 90 minutes. The percentage of HSCs in S+G2M
stage was determined by FACS [9].
Flow cytometry
The percentages of LT-HSCs, LT-LSCs (both CD34
2 LSK),
ST-HSCs+MPPs, ST-LSCs+MPPs (both CD34
+ LSK), as well
myeloid progenitor cells (non-leukemic and leukemic), were
determined by flow cytometry following the isolation of bone
marrow cells of mice that had been transplanted with cells
derived from Selp
2/2 and WT donors. Animals were sacrificed at
14 d post-transplant (in the case of the MIG-p210 transplant) or
18 d post-transplant (in the case of the MIG repopulation
transplant) in order to observe changes in these blood cell
populations and the disease developed. Prior to analysis, bone
marrow cells were incubated in an NH4Cl red blood cell lysis
buffer (pH 7.4) to facilitate the removal of erythrocytes. Single
cells were analyzed for viability by propidium iodide staining.
Viable cells were deemed transduced by MIG or MIG-p210
retrovirus if they expressed GFP. In cells transduced by the
MIG-p210, cells expressing GFP were deemed leukemic, as this
was an indication that BCR-ABL was simultaneously being
expressed from the same bicistronic construct. Viable GFP
+ cells
were stained with Lin, Sca1, c-Kit (CD117), CD34, and CD16/
32 in order to determine the percentages of stem cells and
progenitors attributable to the donor transplantation of cells.
Antibody to P-selectin was purchased from eBioscience (San
Diego, CA).
Bone marrow competition assay
Bone marrow cells were isolated from 18–20-week-old trans-
genic female UBC-GFP mice and Selp
2/2 mice. Erythrocytes were
lysed as previously described. HSCs that are Lin low/Sca1
+/c-kit
+
(LSK) were isolated and collected by sterile FACS. LSK cells from
UBC-GFP and Selp
2/2 mice were mixed in a 1:1 ratio. Recipient
female WT mice were subjected to two rounds of 550 cGy
irradiation and injected with 1610
4 total LSK cells (5610
3 cells of
each). The following day, the same recipient female WT mice
were injected with whole bone marrow cells derived from CD45.1
female mice to ensure survival. At 30, 45, 86, and 120 d post-
transplantation of UBC-GFP and Selp
2/2 cells, peripheral blood
was collected and subjected to flow cytometric analysis. CD45.2
+
cells were determined to be GFP
+ or GFP
2. At 120 d post-
transplantation, recipient mice were sacrificed, and bone marrow
was analyzed to determine the percentage of CD45.2 GFP
+ and
GFP
2 cells, and more specifically, HSC-containing LSK and LT-
HSC.
Homing experiment
We compared the ability of Selp
2/2 and WT marrow cells to
home to the bone marrow compartment of recipients. Bone
marrow cells from UBC-GFP and either Selp
2/2 or WT mice (all
CD45.2) were 1:1 mixed and then injected into CD45.1 recipient
mice. The percentages of CD45.2
+GFP
+ (UBC-GFP) and
CD45.2
+GFP
2 (Selp
2/2) cells in the bone marrow of CD45.1
recipient mice were compared after 3 h. For the HSC homing
assay, we normalized LSK cells and injected around 3610
6 bone
marrow cells of either WT or Selp
2/2 into CD45.1 recipient mice.
The total number of CD45.2
+ LSK cells was calculated after 3 h.
Statistical analyses were performed using GraphPad Prism
v5.01 software for Windows, (GraphPad Software, San Diego, CA
USA).
Loss of P-Selectin Promotes HSCs and LSCs
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Loss of Selp expression supports bone marrow
repopulation
We previously showed a role for P-selectin in our mouse model
for human CML. In that study, we demonstrated that Selp
2/2
recipients of Selp
2/2 donor cells developed CML more quickly
than WT recipients of WT donor cells. In this study, we wanted to
better understand the role P-selectin plays on donor cell function,
irrespective of the recipient stromal contribution, during normal
hematopoiesis and during Ph
+ leukemogenesis in mice.
We infected bone marrow cells derived from 5-FU-treated
donor WT and Selp
2/2 mice with retrovirus expressing GFP.
Irradiated WT recipients were transplanted with 2610
5 of these
transduced donor cells. At 18 d post-transplant, recipients of Selp
2/2
donor cells exhibited significantly higher percentages of HSC-
containing LSK cells than the recipients of WT marrow cells. Selp
2/2
recipients possessed elevated percentages of LT-HSCs (CD34
2 LSK)
and significantly increased percentages of ST-HSCs + MPPs (CD34
+
LSK). Selp
2/2 recipients also possessed significantly elevated
percentages of CMPs, GMPs, and MEPs (Fig. 1A). These data
indicate that the loss of Selp expression supports bone marrow cell
repopulation in irradiated recipients and thus may impart a
functional advantage. These findings were supported by the fact
viral transduction efficiencies did not favor the transduction of Selp
2/2
cells over WT cells (Fig. 1B) and that the percentages of LSK cells after
four days of stem cell culture were very similar (Fig. 1C).
Loss of Selp expression supports HSC long term
engraftment
We sought to characterize the underlying mechanism that
enabled Selp
2/2 bone marrow cells to more efficiently repopulate
the bone marrow space than WT cells. Using a competitive
repopulation assay to test long-term engraftment (Figure 2A),
HSC-containing LSK cells derived from Selp
2/2 mice
(CD45.2
+GFP
2) and UBC-GFP mice (CD45.2
+GFP
+) were mixed
in 1:1 ratio and transplanted into irradiated CD45.1 recipients.
Cells derived from Selp
2/2 recipients exhibited a competitive
advantage over the cells derived from UBC-GFP mice by 45 d
post-transplant that increased by 86 d and 120 d post-transplant
(Fig. 2A). Recipients were sacrificed at 120 d post transplantation
and characterized for the percentages of LSK cells and, in
particular, LT-HSC (CD34
2 LSK) cells in the bone marrow of the
recipients (Fig. 2B). We noted that Selp
2/2 cells more efficiently
engrafted in the bone marrow than WT cells, as indicated by
increased levels of HSC-containing LSK cells and LT-HSCs
(CD34
- LSK). We performed a secondary transplantation assay to
characterize Selp
2/2 LSK self-renewal function (Fig. 2C). Primary
CD45.1 recipients were transplanted with bone marrow cells from
WT or Selp
2/2 mice. At 30 d, primary recipients were sacrificed
and CD45.1 bone marrow cells were collected. Cells were
normalized to ensure equivalent input of HSC-containing LSK
cells prior to secondary transplantation into CD45.1 recipients. At
120 d post-secondary transplantation, a significantly higher
percentage of Selp
2/2 HSC-containing LSK cells and LT-HSCs
(CD34
2 LSK) were detected in the bone marrow of recipients.
We tested the idea that the increased repopulation we observed
was due to an enhanced homing velocity in Selp
2/2 cells by
performing a competitive bone marrow homing assay (Fig. 2D).
Bone marrow cells from the UBC-GFP mouse and those from
Selp
2/2 mouse were mixed in a 1:1 ratio and then injected into
CD45.1 mice. Percentages of CD45.2
+GFP
+ (WT) and
CD45.2
+GFP
2 (Selp
2/2) cells in the bone marrow of CD45.1
recipient mice were compared after 3 h. These findings indicated
that Selp
2/2 donor cells were not as efficient as WT cells in
homing and that the enhanced repopulation of HSC-containing
LSK cells observed in recipients of Selp
2/2 donor cells was not
caused by an accelerated homing velocity. We then performed a
HSC homing assay (Fig. 2E). LSK cells from Selp
2/2 or WT mice
were normalized and injected into recipient mice. At 3 h post-
transplant, animals were sacrificed and the numbers of HSC-
containing LSK cells were counted. Selp
2/2 recipients possessed
modestly lower levels of LSK cells than WT recipients. Although
these data are not statistically significant, the results are consistent
with the competitive bone marrow homing assay, which suggest a
decreased homing velocity.
We next wanted to determine whether Selp
2/2 mice exhibited
changes in HSC quiescence (Fig. 2F). Bone marrow cells isolated
from Selp
2/2 and WT mice exhibited no changes in HSC
quiescence, as measured by the percentage of LSK cells in the S +
G2/M stages of the cell cycle.
P-selectin expression exhibits an age-independent
increase in expression on LT-HSCs
P-selectin expression increases on the surface of HSCs with age
[1]. We sorted LT-HSCs (CD34
2 LSK) and ST-HSCs + MPPs
(CD34
+ LSK) from the bone marrow of 2 month-old, 6 month-
old, and 15 month-old WT mice to determine whether the
increase was restricted to either HSC subpopulation. No changes
were noted between 2 month-old and 6 month-old mice; however,
P-selectin expression on the surface of LT-HSCs was increased in
15 month-old mice. Expression on ST-HSCs + MPPs remained
unchanged (Fig. 3A). These findings correlated with previous
microarray and qRT-PCR data [2].
Loss of P-selectin expression alters stem, progenitor, and
mature cell fates in an age-dependent manner
Selp
2/2 and WT mice were aged for 6, 8, 9, 10, and 11 months.
We collected bone marrow cells from these mice at each of these
time points for FACS analysis of HSC-containing LSK cells and
Figure 1. Selp
2/2 donor cells more efficiently repopulate the bone marrow than controls. Representative FACS analyses (top) comparing
the bone marrow cell populations of recipients of 5-FU pretreated WT and Selp
2/2 cells pre-stimulated with IL3, IL6, and SCF and transduced twice
with a MSCV-based retrovirus expressing GFP (as a marker for evidence of infection) at 18 d post-transplantation. Viable GFP
+ singlets were stained
with antibodies to Lineage (Lin), c-Kit, Sca-1, CD34, and CD16/32. HSCs derived from donors were GFP
+ and Lin
2, Sca-1
+, and c-Kit
+ (LSK). LT-HSC was
GFP
+, CD34
2 LSK; and ST-HSC + MPP were GFP
+, CD34
+ LSK. CMP were GFP
+, CD34
+, Lin
2, Sca-1
2, c-Kit
+, and CD16/32
2. GMP were GFP
+, CD34
+,
Lin
2, Sca-1
2, c-Kit
+, and CD16/32
+, and MEP were GFP
+, CD34
2, Lin
2, Sca-1
2, c-Kit
+, and CD16/32
2. (Bottom) Recipients of Selp
2/2 cells (N=5)
possessed significantly more HSC-containing LSKs than recipients of WT cells (N=4) (P=0.0259). There were considerably more LT-HSC cells in the
Selp
2/2 recipients, although not statistically significant . Recipients of Selp
2/2 cells had significantly more ST-HSCs + MPPs, CMP, GMP, and MEP . (B)
Viral transduction efficiency of WT (WT) and Selp
2/2 HSCs. The bone marrow cell populations of WT and Selp
2/2 were pre-stimulated with IL3, IL6,
and SCF, transduced with a MSCV-based retrovirus expressing GFP and cultured for 48 h. Viable GFP+ LSK cells of WT and Selp
2/2 were compared by
FACS. (C) The percentage of HSCs between WT and Selp
2/2 after culture for 4 d. The bone marrow cells of WT and Selp
2/2 were cultured under stem
cell conditions for 4 d. The percentage of viable LSK cells of WT and Selp
2/2 were compared by FACS. For each experiment, the following denote the
statistical significance observed: 0.01,P,0.05= *; 0.001,P,0.01= **; P,0.001=***.
doi:10.1371/journal.pone.0026246.g001
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numbers of bone marrow cells at 6, 8, 9, and 10 months of age,
while there was a higher total of bone marrow cells in Selp
2/2
mice at 11 months of age when compared to the WT control.
Overall, loss of Selp expression appeared to increase the total
numbers of HSC-containing LSK cells in mice at 6 months of age,
but this effect diminished with age. This finding corresponded with
the levels of ST-HSC + MPPs that were observed. In contrast,
there were increased levels of LT-HSCs (CD34
2 LSK) in the
Selp
2/2 mice when compared to controls at most time points,
except at 9 months. At 11 months, there was a significant increase
in the levels of LT-HSCs present. There were significantly more
CMPs in Selp
2/2 than in WT mice at 6 and 8 months, but this
difference dissipated by 9 months. While it had no effect on GMP
populations, loss of Selp expression caused a marked expansion the
MEP populations at each time point tested. We observed an
increasing number of Gr1
+ cells present in the bone marrow, with
a significant difference noted at 11 months. This corresponded to
Gr1
+ levels that were observed in the peripheral blood. While no
significant differences were observed in the numbers of total
leukocytes present in the peripheral blood until 11 months, there
was a marked increase in the Gr1
+ cells in the peripheral blood by
9 months that remained through 10 and 11 months. These
findings were indicative of strain- and age-dependent effects on
stem, progenitor, and mature myeloid cell populations.
Loss of Selp enhances the function of leukemia stem cells
Because loss of Selp expression enhances HSC function
(Figure 1,2), we examined whether Selp also regulates the function
of leukemia stem cells (LSCs) using a BCR-ABL-induced CML as
a disease model. CML is a stem cell disease, and we have
previously identified LSCs for CML in mice [10]. We have
previously shown that loss of Selp causes acceleration of CML
development [4], but it is unknown whether this is caused by a P-
selectin-mediated effect resulting from its expression on the surface
of LSCs. Bone marrow cells from 5-FU-treated donor WT and
Selp
2/2 mice were infected with retrovirus expressing BCR-ABL-
GFP. Irradiated WT recipients were transplanted with 2610
5 of
these transduced donor cells. At 14 d post-transplant, recipient
mice from each of the groups were sacrificed, and bone marrow
cells were harvested and analyzed by FACS (Fig. 4). Recipients of
leukemic Selp
2/2 cells possessed significantly more LSC-contain-
ing LSK cells than recipients of WT cells. There were more LT-
LSCs (CD34
- LSK) and ST-LSCs + MPPs (CD34
+ LSK) in
recipients of Selp
2/2 cells than WT cells. In addition, recipients of
leukemic Selp
2/2 cells possessed significantly more CMP and MEP
cells.
Mouse recipients of Selp
2/2 BCR-ABL-expressing donor
cells develop a more insidious CML-like disease
Bone marrow cells derived from 15-month-old donor Selp
2/2
and WT mice were transduced with BCR-ABL, respectively,
followed by transplantation of the transduced cells into recipient
mice. Leukemia cells (GFP
+/Gr1
+) in peripheral blood of
recipients of BCR-ABL transduced Selp
2/2 cells are significant
higher than those in recipients of the transduced WT cells
(Figure 5A). All recipients of BCR-ABL transduced Selp
2/2 cells
died by 23 d after induction of CML and had a median survival of
19 d, whereas recipients of the transduced WT cells survived
significantly longer (Fig. 5B).
Discussion
In a previous study, we showed that Selp
2/2 recipients of Selp
2/2
donor bone marrow transduced by BCR-ABL developed a more
aggressive form of CML-like disease than the recipients of WT cells
[4]. We demonstrated that in the absence of P-selectin expression in
both donor cells and recipient stroma, BCR-ABL-expressing
progenitors are prematurely released from the bone marrow due
to an apparent adhesion defect; and this leads to significant
pulmonary hemorrhages and cellular masses due to massive
infiltration of myeloid leukemia cells. P-selectin expression has been
associated with platelets and endothelial cells [3] and is known to
contribute to variety of processes including coagulation, inflamma-
tion, and tumor metastasis [11,12]. The traditional view was that
stromal, P-selectin-expressing endothelial cells interact with P-
selectin ligand-bearing (PSGL1) leukocytes and facilitate an
assortment of processes including adhesion and rolling and cellular
activation [13]. In addition, platelets expressing P-selectin are
capableofbindingdirectlytoleukocytes,contributingtorolling,and
to tumor cells, supporting metastasis [12]. Recent findings that
HSCs express P-selectin [14] and the finding that the level of P-
selectin expression on LT-HSCs increases with age (Ref. [2] and
Figure 3A) confound the current understanding of its role in
mediating the leukocyte-stroma interaction [1,14] and may have
important implicationsforleukemogenesis [2]. This studyaddressed
Figure 2. Selp
2/2 donor cells exhibit diminished homing velocities but longer-term repopulation advantages over controls. (A,B)
CD45.2 LSK cells derived from Selp
2/2 and UBC-GFP mice were sorted by sterile technique and mixed in a 1:1 ratio. (A) Peripheral blood was extracted
from recipients at 30 d (N=6), 45 d (N=6), 86 d (N=5), and 120 d (N=3) post-transplantation and subjected to FACS analysis (top). The CD45.2 cell
population was assayed, and the percentage of GFP
+ (UBC-GFP) and GFP- (Selp
2/2) cells were determined. Data are represented as the mean 6 SEM.
One sample t-tests (theoretical means =50%, assuming no competitive advantage) were applied to the data. Statistically significant differences were
not observed at 30 d (P=0.9639) but became apparent at 45 d, 86 d, and 120 d (P=0.0113). (B) The percentage of HSC-containing LSK cells, and
specifically CD34
2 LSK LT-HSCs, either GFP
+ or GFP
2, in bone marrows from recipients at 120 d (N=3) post-transplantation were determined by FACS
analysis. Data are represented as the mean 6 SD. HSC-containing LSK cells and CD34
2 LSK LT-HSC derived from Selp
2/2 exhibited a competitive
advantage. (C) The HSCs of Selp
2/2 self-renew significantly more than WT HSCs in 2nd transplantation experiment. The bone marrow cells from
primary recipient were collected and transplanted into secondary recipients at 30 d post primary transplantation. The percentage of LSK cells and
CD34
2 LSK LT-HSC cells in the bone marrow of the recipients (Selp
2/2) cells were determined at 120 d post 2nd transplantation. Data are represented
as the mean 6 SD (N=4). (D) Homing assay reveals decreased homing velocity for Selp
2/2 cells relative to UBC-GFP controls. Bone marrow cells from
Selp
2/2 or WT mice (both CD45.2 background) were mixed in a 1:1 ratio with UBC-GFP cells (CD45.2) and injected into CD45.1 recipients. Three hours
post-injection, recipients were sacrificed and the percentages of CD45.2/GFP
+ and CD45.2/GFP- cells were measured by FACS (representative FACS,
left panel). The average ratios of WT to UBC-GFP or Selp
2/2 to UBC-GFP cells are presented. Selp
2/2 cells exhibited a significant homing defect
relative to controls. (E) HSC homing assay reveals a decreased homing velocity for Selp
2/2 LSK cells relative to WT controls. Bone marrow cells from
Selp
2/2 or WT mice were respectively injected into CD45.1 recipients (HSCs were normalized by FACS before injection). Three hours post-injection,
recipients were sacrificed and the percentages of CD45.2
+ LSK were measured by FACS (representative FACS, left panel). The average cell number
(LSK) of WT or Selp
2/2 are presented. (F) Cell cycle analysis of WT and Selp
2/2 HSCs. Bone marrow cells were isolated from Selp
2/2 or WT mice. LSK
cells were stained with Hoechst blue, and LSK cells in S+G2M phase of the cell cycle were examined by FACS. No significant differences were
observed. For each experiment, the following denote the statistical significance observed: 0.01,P,0.05= *; 0.001,P,0.01= **; P,0.001=***.
doi:10.1371/journal.pone.0026246.g002
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HSCs (CD34
2 LSK) and ST-HSCs+MPPs (CD34
+ LSK) were sorted by FACS from the bone marrow of 2 month-old, 6 month-old, and 15 month-old WT
mice and tested for surface P-selectin expression (N=3). Representative FACS show that CD34
2 LSK LT-HSCs exhibit age-dependent increases in
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and LSC populations and function. Indeed, we have demonstrated
that P-selectin expression on the surface of HSCs and progenitors is
critical to their function and thus normal myelopoiesis and may
contribute to Ph
+ chronic myeloid leukemogenesis. We showed that
the loss of P-selectin expression facilitated bone marrow repopula-
tion by LSK populations including LT-HSCs (CD34
2) and ST-
HSCs + MPPs (CD34
+) (Fig. 1). In addition, significant differences
in progenitor populations were noted. These differences were cell-
dependent, as Selp
2/2 cells were not more susceptible to viral
transduction than WT cells. Furthermore, we cultured of Selp
2/2
and WT LSK cells in vitro and noted no significant differences in
surface P-selectin expression but CD34
+ LSK ST-HSCs + MPPs do not. (B) Data collected from FACS analyses of bone marrow cells (B) WT and Selp
2/2
mice aged 6, 8, 9, 10, or 11 months. Data represent the mean absolute numbers (6 SD) of LSK, CD34
2 LSK LT-HSC, CD34
+ LSK ST-HSC + MPP, CMP,
GMP, or MEP. Following two-way ANOVA, Bonferroni post-tests comparing Selp
2/2 mice to WT mice at each age point were executed. Significant
differences between Selp
2/2 and WT HSC and progenitor populations were noted (0.01,P,0.05= *; 0.001,P,0.01= **; P,0.001=***).
doi:10.1371/journal.pone.0026246.g003
Figure 4. Recipients of 5-FU pretreated Selp
2/2 donor cells transduced to express BCR-ABL more efficiently repopulate the bone
marrow of recipients than controls. (A) CML was induced in recipient mice using BCR-ABL-transduced bone marrow taken from 5-FU pre-treated
donor Selp
2/2 or WT mice pre-stimulated with IL3, IL6, and SCF. Representative FACS (top panel) compares recipients of Selp
2/2 -derived cells to WT-
derived cells. The mean data (bottom panel) revealed statistically significant elevations in the percentages of LSCs (CD34
2 LSK LT-LSCs and CD34
+ LSK
ST-LSCs + MPPs) and progenitors (CMP, GMP, and MEP). (0.01,P,0.05= *; 0.001,P,0.01= **).
doi:10.1371/journal.pone.0026246.g004
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at the HSC level, where Selp
2/2 LSK cells exhibited a long-term
competitive advantage over WT LSK cells (Figure 2B). This
competitive advantage at the stem cell level led to the increased
number of Selp
2/2 cells present in the peripheral circulation
(Fig. 2A), as well as in the bone marrow space (Fig. 2B). We
attributed the advantage Selp
2/2 cells possess over WT cells to an
enhanced capacity for self-renewal (Fig. 2C). We observed that this
functional advantage was not attributable to an enhanced homing
velocity, as WT cells homed more efficiently than Selp
2/2
(Figure 2D–E). These findings are surprising in that we had
previously shown through an alternative method that Selp
2/2 and
WT cells homed with similar efficiencies when introduced into
recipients of the same genetic background [4]. In this paper, the
approach differed and relied upon a CD45.1 recipient. Thus, effects
from different microenvironments (Selp
2/2 vs. WT) on donor cell
homing could be avoided. This enabled us to focus our homing
assay on the donor cells and not the recipient stroma. Our findings
indicate an initial competitive disadvantage for Selp
2/2 donor cells
because of a presumed inability to be retained in the bone marrow
space. We speculate that the premature release of Selp
2/2 cells from
the bone marrow may result in a compensatory increase in levels of
Selp
2/2 cells. Alternatively, it is possible that other adhesion
mechanisms may predominate in spite of Selp expression or at least
may compensate for loss of function when Selp is not expressed. In
the long term, Selp
2/2 cells possess a competitive advantage due to
enhanced stem cell self-renewal properties.
We have previously shown that BCR-ABL-transformed HSCs
exhibiting the LSK expression profile function as de facto CML
stem cells [10]. In this paper, we demonstrate that in the absence
of P-selectin expression on LSCs, a more aggressive form of CML
develops, as indicated by the elevated percentage of LSCs
observed in the bone marrow (Fig. 4) and the decline in mean
survival time following transplantation of leukemic cells (Fig. 5).
The aggression with which CML proceeds is dependent on the
donor LSC/progenitor. In fact, both LT-LSC (CD34
2 LSK) and
ST-LSC + MPP (CD34
+ LSK) percentages were increased in the
bone marrow, and, as a result, the total number of leukemic cells
in peripheral blood was increased. The increase in the percentage
of LSCs is mostly attributable to the cell-intrinsic differences
related to the expression of P-selectin. It has been speculated that
LT-HSCs, when transformed, may actually be the true stem cell
source for most myeloid leukemias [2]. With aging, there is an
increase in LT-HSCs (Fig. 3); however, unlike LT-HSCs found in
younger people, aged LT-HSC are often homeostatically disrupt-
ed [15], and exhibit increasing levels of self-renewal and an
unusual propensity to generate more myeloid than lymphoid
progenitors [2]. This disruption in the lymphoid/myeloid balance,
coupled with the overall elevation in LT-HSCs, contributes to
making Ph
+ CML more common with age (according to NCI
SEER 2001–2005, median age of diagnosis in the U.S. =66 yrs.
Figure 5. Recipients of Selp
2/2 derived from 15 month old donors develop a more aggressive CML-like disease than age-matched
controls. CML was induced in recipient mice using BCR-ABL-transduced bone marrow cells taken from 5-FU treated 15 month old donor Selp
2/2 or
WT mice pre-stimulated with IL3, IL6, and SCF. FACS analysis (A, left panel) showed GFP
+Gr-1
+ cells in peripheral blood of recipients of BCR-ABL
transduced Selp
2/2 and WT cells from old donors. (A, right panel) At 13 d post-transplant, Selp
2/2 recipients (N=10) possessed significantly more
GFP
+Gr1
+ cells in the peripheral circulation than WT recipients (N=9). (B) Kaplan-Meier survival analysis revealed an accelerated form of CML in
recipients of aged Selp
2/2 marrow cells (N=10) retrovirally transduced with BCR-ABL when compared to recipients of WT bone marrow cells (N=9)
retrovirally transduced with BCR-ABL. For each experiment, the following denote the statistical significance observed: 0.01,P,0.05= *;
0.001,P,0.01= **; P,0.001.
doi:10.1371/journal.pone.0026246.g005
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in HSC-containing LSK cells that loss of Selp expression increased
the capacity for their self-renewal (Fig. 2). In the context of CML,
we postulate that the loss of Selp expression increases LSC self-
renewal, thereby accelerating leukemogenesis. In older mice, loss
of Selp expression may have additive or synergistic effects on
leukemia development.
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